Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Suzanne Jaqueth Forrest, M.D.

Concepts (81)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
High-Throughput Nucleotide Sequencing5202436510.580 Why?
Information Dissemination1202411420.510 Why?
Molecular Targeted Therapy3202428220.390 Why?
Neoplasms62024223450.370 Why?
Glioma1202234930.280 Why?
Medical Oncology1201823390.250 Why?
Pediatrics1201836040.200 Why?
Brain Neoplasms1202290710.180 Why?
Mutation32024301840.170 Why?
Child122024804990.160 Why?
Muscular Atrophy, Spinal220122600.150 Why?
Proto-Oncogene Proteins c-ret120202280.150 Why?
Fibrosarcoma120203130.150 Why?
Resource Allocation120203540.150 Why?
Microtubule-Associated Proteins1202210650.140 Why?
Osteosarcoma120239090.140 Why?
Oncogenes1202212320.140 Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma120203850.130 Why?
Interleukin-21202318960.130 Why?
Infant62024363630.130 Why?
Child, Preschool72024424680.120 Why?
Specimen Handling120207030.120 Why?
Neoplasm, Residual1202010090.120 Why?
Central Nervous System Neoplasms120239170.120 Why?
Antineoplastic Agents12018136390.120 Why?
Base Sequence12022124020.090 Why?
Soft Tissue Neoplasms1202011630.090 Why?
Genomics2202459240.090 Why?
Graft vs Host Disease1202330780.090 Why?
Bone Neoplasms1202325640.090 Why?
Adolescent62024887810.080 Why?
Clinical Trials as Topic1202480380.070 Why?
Infant, Newborn22024263320.070 Why?
Ovarian Neoplasms1202349000.070 Why?
Protein Kinase Inhibitors1202256930.060 Why?
Prognosis32023298990.060 Why?
Biomedical Research1202034580.060 Why?
Gene Expression Regulation, Neoplastic1202086030.050 Why?
Humans1420247657340.050 Why?
DNA Copy Number Variations1201220450.050 Why?
Survival of Motor Neuron 2 Protein22012490.050 Why?
Follow-Up Studies22020391800.050 Why?
Loss of Heterozygosity120236630.050 Why?
Oncogene Fusion12020840.040 Why?
Antineoplastic Combined Chemotherapy Protocols12020118650.040 Why?
Tissue Banks120201830.040 Why?
BRCA2 Protein120238010.040 Why?
Gene Amplification1202310890.040 Why?
Female620243959610.040 Why?
Male520243635850.040 Why?
BRCA1 Protein1202311540.030 Why?
Clinical Trials, Phase III as Topic120208780.030 Why?
Young Adult42023598520.030 Why?
Germ-Line Mutation1202318830.030 Why?
Remission Induction1202024090.030 Why?
Severity of Illness Index12012158830.030 Why?
Phenotype12012167060.030 Why?
Analysis of Variance2201262030.030 Why?
Motor Activity2201227050.020 Why?
Oncogene Proteins, Fusion1202016080.020 Why?
Gas Chromatography-Mass Spectrometry120123550.020 Why?
Prospective Studies32023547950.020 Why?
Fatty Acids, Nonesterified120123930.020 Why?
Biopsy1202067540.020 Why?
Chromatography, Liquid120129900.020 Why?
DNA Primers1201228230.020 Why?
Gene Dosage1201212130.020 Why?
Immunotherapy1202347520.020 Why?
Survival Rate12020127870.020 Why?
Amino Acids1201217090.020 Why?
Tandem Mass Spectrometry1201211930.020 Why?
Case-Control Studies22012222240.010 Why?
Randomized Controlled Trials as Topic12020103850.010 Why?
Retrospective Studies22023814570.010 Why?
Metabolomics1201216680.010 Why?
Cross-Sectional Studies22012262840.010 Why?
Pilot Projects1201287320.010 Why?
Proteomics1201239100.010 Why?
Adult220222229740.010 Why?
Gene Expression Profiling1201295220.010 Why?
Age Factors12012183750.010 Why?
Forrest's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (81)
Explore
_
Co-Authors (63)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.